Related Experiment Video
Updated: Jan 30, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
Published on: October 5, 2020
Acrylamide Functional Group Incorporation Improves Drug-like Properties: An Example with EGFR Inhibitors
Kuen-Da Wu1, Grace Shiahuy Chen2, Jia-Rong Liu1
1School of Pharmacy and Center for Innovative Therapeutics Discovery, National Taiwan University, Taipei 10055, Taiwan.
Abstract:
We demonstrate that the acrylamide group can be used to improve the drug-like properties of potential drug candidates. In the EGFR inhibitor development, both the solubility and membrane permeability properties of compounds 6a and 7, each containing an acrylamide group, were substantially better than those of gefitinib (1) and AZD3759 (2), respectively. We demonstrated that incorporation of an acrylamide moiety could serve as a good strategy for improving drug-like properties.
Related Concept Videos
Properties of Continuous Functions
Antihypertensive Drugs: Direct Renin Inhibitors
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
The drug's acidity or basicity is essential in...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

